What are the common side effects of pemetrexed treatment in an older adult smoker with non-small cell lung cancer or pleural mesothelioma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Side Effects of Pemetrexed in Older Adult Smokers with NSCLC or Mesothelioma

Pemetrexed causes primarily hematologic toxicity in elderly patients, with grade 3/4 neutropenia (33-52%), thrombocytopenia (13-29%), and anemia (19%), along with fatigue (10-56%), nausea (52-56%), and gastrointestinal symptoms as the most common adverse effects. 1, 2

Hematologic Toxicity (Most Common)

The predominant toxicities are blood-related and occur more frequently in elderly patients:

  • Neutropenia: Grade 3/4 neutropenia occurs in 33-52% of elderly patients, which is significantly higher than younger patients (22%) 2, 3
  • Thrombocytopenia: Grade 3/4 occurs in 13-29% of elderly patients versus 6% in younger patients 2, 3
  • Anemia: Grade 3/4 anemia affects 19% of elderly patients 3
  • Febrile neutropenia: Occurs in approximately 4.5-4.8% of patients regardless of age 4, 2

Important caveat: When pemetrexed is combined with carboplatin (common in elderly patients), grade 3/4 neutropenia increases to 36.1% compared to 23.9% with cisplatin 5

Non-Hematologic Toxicity

Gastrointestinal Effects

  • Nausea: Occurs in 52-56% of patients (grade 3-4 in 3.5%) 1
  • Constipation: Affects 35% of patients 1
  • Diarrhea: Occurs in 31% (grade 3-4 in 2-3%) 1
  • Vomiting: Affects 24% of patients 1
  • Anorexia/decreased appetite: Occurs in 28-30% 1

Constitutional Symptoms

  • Fatigue/asthenia: The most common non-hematologic toxicity, occurring in 56% of patients (grade 3-4 in 10-16%) 1, 3
  • Pyrexia: Affects 20% of patients 1

Other Notable Toxicities

  • Rash: Occurs in 25% of patients (grade 3-4 in 2%) 1
  • Cough and dyspnea: Each affects approximately 21-28% of patients 1

Critical Safety Concerns

Renal Toxicity

  • Acute kidney injury is a leading cause of pemetrexed discontinuation (3% of patients) 1
  • Increased risk with NSAIDs: In patients with creatinine clearance 45-79 mL/min, avoid ibuprofen for 2 days before, day of, and 2 days after pemetrexed administration due to increased drug exposure and toxicity risk 1

Pulmonary Toxicity

  • Pneumonitis: Occurs in approximately 2% of patients and is a common reason for discontinuation 1
  • Interstitial lung disease: Can occur, particularly in elderly patients (grade 3+ in rare cases) 5, 1

Severe Skin Reactions

  • Bullous and exfoliative skin toxicity can occur, requiring permanent discontinuation 1
  • Radiation recall: Can develop in patients who received prior radiation therapy 1

Special Considerations for Elderly Smokers

Critical point: Pemetrexed should NOT be used in patients with squamous cell histology, which is more common in smokers 5

  • Elderly patients (≥70 years) experience more frequent hematologic toxicity compared to younger patients, particularly when combined with carboplatin 5
  • Treatment-related deaths have been observed in elderly patients, particularly with multi-drug combinations 5
  • Despite increased toxicity, efficacy outcomes (response rates, progression-free survival, overall survival) are similar between elderly and younger patients 5, 2

Toxicity Mitigation

Mandatory supplementation: All patients must receive vitamin B12 and folic acid supplementation to significantly reduce toxicity incidence and severity without compromising efficacy 1, 4, 6

Common pitfall: Failure to provide vitamin supplementation dramatically increases toxicity rates and should never be omitted 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.